Cara Therapeutics Stock Quote CARA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.652301

Bid

0.6522

Ask

0.6599

Volume

171,673

0.65 Day's Range 0.6958

0.50 52 Week Range 4.6699

Market Cap

36.073M

Previous Close

0.69

Open

0.685

Last Trade

100

0.6528

(average)

Last Trade Time

11:29:46

Financial Volume

$ 114,514

VWAP

0.667046

Average Volume (3m)

661,032

Shares Outstanding

54,656,413

Dividend Yield

PE Ratio

-0.30

Earnings Per Share (EPS)

-2.17

Revenue

20.97M

Net Profit

-118.51M

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.caratherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Cara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CARA. The last closing price for Cara Therapeutics was $0.69. Over the last year, Cara Therapeutics shares have traded in a share price range of $ 0.50 to $ 4.6699.

Cara Therapeutics currently has 54,656,413 shares outstanding. The market capitalization of Cara Therapeutics is $36.07 million. Cara Therapeutics has a price to earnings ratio (PE ratio) of -0.30.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.157699	-19.4690123457	0.81	0.83	0.6311	373995	0.71683276	CS
4	-0.247699	-27.5221111111	0.9	0.96	0.6311	401353	0.81374241	CS
12	0.085301	15.0442680776	0.567	1.15	0.515	661032	0.81016161	CS
26	-0.737699	-53.0718705036	1.39	1.4068	0.5	718257	0.83367012	CS
52	-3.577699	-84.5791725768	4.23	4.6699	0.5	868632	2.12154329	CS
156	-27.697699	-97.6991146384	28.35	28.72	0.5	763192	8.46984078	CS
260	-17.097699	-96.3250647887	17.75	29.6473	0.5	703463	12.21595691	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGOXNext e GO NV	$ 0.0577 (60.28%)	275.07M
NVFYNova Lifestyle Inc	$ 3.1123 (47.50%)	27.13M
SHOTWSafety Shot Inc	$ 0.3998 (33.27%)	6.3k
ZCMDZhongchao Inc	$ 1.92 (32.41%)	28.83M
AGBAAGBA Group Holding Ltd	$ 1.33 (29.13%)	91.76M
SBFMSunshine Biopharma Inc	$ 2.04 (-38.55%)	7.28M
YYAIConnexa Sports Technologies Inc	$ 1.4264 (-31.75%)	6.42M
ISPCiSpecimen Inc	$ 0.29525 (-29.87%)	1.71M
BTOGBit Origin Ltd	$ 2.2683 (-23.88%)	200.8k
BGLCBioNexus Gene Lab Corporation	$ 0.65 (-23.40%)	449.82k
EGOXNext e GO NV	$ 0.0577 (60.28%)	275.07M
AGBAAGBA Group Holding Ltd	$ 1.33 (29.13%)	91.76M
SQQQProShares UltraPro Short QQQ	$ 12.545 (3.94%)	89.31M
SINTSiNtx Technologies Inc	$ 0.0455 (13.75%)	72.64M
TQQQProShares UltraPro QQQ	$ 50.7812 (-3.73%)	42.89M